Viking’s 42% Plunge Splits Experts—A ‘$129 Strong Buy’ Or ‘Clearly Inferior’ Drug?

All NewsAugust 20, 2025

Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it’s inferior.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent